Skip to main content
Clinical Trials/IRCT20211109053013N1
IRCT20211109053013N1
Recruiting
Phase 3

Comparison of efficacy, side effects, and patient satisfaction in patients with limited scalp areata alopecia in a multiple group study with Latanoprost, Minoxidil, and Betamethasone

Iran University of Medical Sciences0 sites108 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
108
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with localized areata alopecia of beard or scalp (\<3 patches)
  • Not receiving any medication for areata alopecia for at least 1 month before the beginning of the study
  • Signing an informed written consent

Exclusion Criteria

  • Patients with extensive alopecia (\> 3 patches)
  • Patients with any systemic disorder , ophthalmic pathology, other dermatological diseases, skin atrophy, or infection at the alopecic region
  • Patients with allergy or hypersensitivity to any component of the treatment products
  • Pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials